Citryll, an Oss, Netherlands-based pharmaceutical company, closed a total funding of €18.5m.
BioGeneration Ventures, a Naarden, The Netherlands-based early-stage VC in European biopharma, closed its fourth fund, BGV IV, at €105m ($119m).
Roamler, an Amsterdam, The Netherlands-based provider of an on-demand workforce platform, raised €20m in funding.
Gatt Technologies, a Nijmegen, Netherlands-based hemostatic solutions company, raised €10.5M in series B financing.
Just Eat Takeaway.com N.V. (LSE: JET, AMS: TKWY), an Amsterdam, The Netherlands-based online food delivery marketplace, raises €700m through an accelerated bookbuild offering of new shares and convertible bonds.
Yoho, an Amsterdam, The Netherlands-based provider of a SaaS connected worker platform, raised further €400K in seed funding.
Mirastar, a specialist developer, investor and manager of industrial and logistics (I&L) assets in Europe, received an investment from KKR.
Utrecht, the Netherlands, and Cambridge, Massachusetts-based Gilde Healthcare closed Gilde Healthcare V, a €416m ($450m) venture and growth capital fund.
HousingAnywhere, a Rotterdam, The Netherlands-based housing platform, acquired Icelandic rental platform Rentmate.
Kaizo, formerly known as Ticketless, Amsterdam, The Netherlands-based startup that aims to actively guide employees towards achieving their goals and making an impact in their companies, raised $3m in seed funding.
Pyramid Analytics, an Amsterdam, the Netherlands-based provider of a next-generation business intelligence (BI) platform for the enterprise, closed a funding round of $25 million.
Everbridge, Inc. (NASDAQ: EVBG), a Boston, MA- and Los Angeles, CA-based provider of critical event management (CEM) solutions, acquired one2many, a Netherlands-based global provider of cell broadcast solutions for safety applications.
UNL, a Singapore- and Amsterdam, The Netherlands-based “Internet of Places” startup, raised $2m in seed funding.
Harbour BioMed, a Cambridge, MA- Rotterdam, The Netherlands and Suzhou, China-based global, clinical stage biopharmaceutical company, closed its $75m Series B+ round of financing.
Toxys, a Leiden, The Netherlands-based biotech company, raised €2m in funding.